Rouleaux Phenomenon as a Prompt for Immediate Evaluation of Plasma‑Cell Dyscrasias

Definition and Clinical Significance

Immediate Laboratory Evaluation When Rouleaux Is Detected

Mandatory Panel for Detecting Monoclonal Proteins

Diagnostic Criteria for Plasma‑Cell Disorders (Based on NCCN/Blood Guidelines)

Symptomatic Multiple Myeloma

Smoldering (Latent) Multiple Myeloma

Monoclonal Gammopathy of Undetermined Significance (MGUS)

All criteria reflect the consensus recommendations of the National Comprehensive Cancer Network and the American Society of Hematology as reported in the cited Blood and JNCCN publications.

Diagnostic Approach to Rouleaux Formation in Blood Smear

Initial Evaluation

• When rouleaux formation is identified on a peripheral blood smear, the diagnostic workup should focus on evaluating for plasma cell disorders, particularly multiple myeloma, as this is the most clinically significant cause requiring prompt intervention 4, 5, 6
• Perform a complete blood count with differential and review the peripheral blood smear for additional findings such as circulating plasma cells, which may accompany rouleaux formation 4, 5, 7
• Order a comprehensive biochemistry panel including liver function tests, renal function tests, electrolytes, calcium, and albumin 6, 8

Specific Testing for Plasma Cell Disorders

• Evaluate both serum and urine for monoclonal proteins using serum protein electrophoresis (SPEP) and urine protein electrophoresis (UPEP) 4, 5, 7
• Evaluate both serum and urine for monoclonal proteins using immunofixation electrophoresis of serum and urine 6, 8
• Evaluate both serum and urine for monoclonal proteins using serum free light chain assay 6, 8
• Evaluate both serum and urine for monoclonal proteins using quantitative immunoglobulins by nephelometry 4, 5, 7
• If monoclonal protein is detected, proceed with bone marrow aspiration and biopsy to assess for clonal plasma cells 4, 5, 6
• If monoclonal protein is detected, proceed with skeletal survey, low-dose whole-body CT, MRI, or PET-CT to evaluate for bone lesions 6, 8

Interpretation of Results

• Diagnose multiple myeloma if the following criteria are met: ≥10% clonal bone marrow plasma cells, presence of serum and/or urinary monoclonal protein, and evidence of end-organ damage (hypercalcemia, renal insufficiency, anemia, bone lesions) 4, 5, 7
• Diagnose smoldering multiple myeloma if: serum monoclonal protein ≥3 g/dL and/or ≥10% clonal bone marrow plasma cells, and absence of end-organ damage 4, 5, 7
• Diagnose monoclonal gammopathy of undetermined significance (MGUS) if: serum monoclonal protein <3 g/dL, <10% clonal bone marrow plasma cells, and absence of end-organ damage 4, 5, 7

Clinical Pearls and Pitfalls

• Nephelometric quantitation may overestimate monoclonal protein concentration when values are high 4, 5, 7
• Never delay appropriate workup when rouleaux is identified, as it may be the first indication of a plasma cell dyscrasia requiring urgent intervention 4, 5, 6